About
This forum is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in cytokine signalling. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of cytokines and cytokine signalling, and its implications for clinical practice.
The programmes are free from commercial bias, and feature leading experts sharing their knowledge and experience in the form of video tutorials.
Podcasts
Difficult-to-treat disease in Rheumatology Podcast Professors Iain McInnes and Peter Nash
Podcasts
Discussing RA: Impact of TOF on BMI, UPA monotherapy in MTX-IRs, and JAKis vs TNFis treatment
Podcasts
Podcast: AuToDeCRA, June 2025
Podcasts
Discussing PsA: Real-world data on biologic switching and the development of EMMs
Podcasts
Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA
Podcasts
Webinar Highlights Podcast: Advancing Patient Care Through an Interdisciplinary Approach to IMIDs
Podcasts
Author Interview: Dr Saqr Alsakarneh, May 2025
Podcasts
Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA
Podcasts
Discussing RA: MACE, VTE, and malignancy in filgotinib RA and UC patients, and MACE related to JAKis
Podcasts
Webinar Highlights Podcast: IL-17 Inhibition: Controlling inflammation and disease progression in SpA
Podcasts
Discussing PsA: JAKi Comparative safety and Burden and determinants of multi‑b/tsDMARD failure in PsA
Podcasts
Discussing RA: Pain reduction & choosing second-line DMARDs after unresponsive first-line DMARDs
Podcasts
Author Interview: Professor Phillip Helliwell, March 2025
Podcasts
Author Interview: Professor Philip Helliwell, 2025
Podcasts
Discussing PsA: Bimekizumab improves patient-reported outcomes and work productivity
Podcasts
Discussing axSpA: Long-term safety and efficacy of Bimekizumab results from BE-AGILE & BE-MOBILE 1/2
Podcasts
Discussing RA: Baricitinib dose reduction and switching to bDMARDs vs JAKis
Podcasts
Author Interview: Professor Denis McGonagle, 2025
Podcasts
Discussing RA: Insights into sustained DMARD-free remission and barriers to CAR T-cell therapy
Podcasts
Discussing RA: Insights into Filgotinib and Tofacitinib in RA
Podcasts
Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib
Podcasts
PsA Podcast: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses
Podcasts
Discussing RA: Insights into Filgotinib and Tofacitinib in RA
Podcasts
Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases
Podcasts
AxSpA Podcast: Efficacy and Safety of IV secukinumab
Podcasts
Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy
Podcasts
Author Interview: Derin Karacabeyli, 2024
Podcasts
Webinar Highlights Podcast 2: Evolving Therapeutic Strategies for Psoriatic Diseases
Podcasts
PsA Podcast: Bimekizumab: Efficacy, safety, and effectiveness in PsA
Podcasts
Discussing RA: Long-term safety and efficacy of upadacitinib in SELECT trials
Podcasts
Discussing AxSpA: Incidence of uveitis following bimekizumab treatment
Podcasts